The two-year patent war between Contemporary Amperex Technology Co., Limited（CATL）and CALB has reversed.On the evening of August 3, CALB announced that the CNIPA had issued two "Examination Decision on Request for Invalidation", respectively claiming the "lithium-ion battery" and "positive electrode

On July 24, it’s reported by CCTV News today that at the 2023 China Automobile Innovation Conference held on July 23, China Automobile Technology and Research Center Co., Ltd. and Peking University jointly released the "Blue Paper on Automotive Standard Essential Patents", which is China’s first sys

Recently, CNIPA issued its Decision on the Awarding of the 24th China Patent Award. The invention patent "EGFR Inhibitor and Preparation and Application Thereof" (Patent No.: ZL 201580045311.2) for the innovative drug Ameile (Aumolertinib Mesylate Tablets) developed by Hansoh Pharma, won the 24th Ch

Livzon Group announced that it signed the "Patent and Technology Transfer Agreement" with Shanghai Synergy Pharmaceutical Sciences Co., Ltd. on July 19, 2023. According to the agreement, Synergy Pharmaceutical Sciences agreed to transfer and transfer all the rights, ownership, and interests of the H

At the press conference, Hu Wenhui, deputy director of CNIPA, gave a brief introduction to the relevant situation of intellectual property work in the first half of 2023.1. Main DataFor patents: in the first half of the year, a total of 433,000 invention patents, 1.104 million utility model patents,